Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
PreventionGenetics, part of Exact Sciences United States | 36 | 27 |
|
Rhizomelic Chondrodysplasia Punctata Type 3 via the AGPS Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Peroxisomal disorders panel. NGS panel of 27 genes. Genologica Medica Spain | 45 | 27 |
|
Central skeletal dysplasias panel. NGS panel of 111 genes. Genologica Medica Spain | 258 | 111 |
|
Chondrodysplasia punctata panel. 9-gene NGS panel. Genologica Medica Spain | 14 | 9 |
|
Peroxisomal Disorder Panel, Sequencing ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 17 | 26 |
|
Peroxisomal Disorders Gene Panel Duzen Laboratories Duzen BBAGUAS Turkey | 39 | 30 |
|
Natera, Inc. United States | 244 | 254 |
|
AGPS Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
AGPS Gene Sequencing by Massively Parallel Sequencing (BCM-NGSSM) Baylor Genetics United States | 1 | 1 |
|
AGPS Sequence Analysis (Prenatal Sequence Analysis) Baylor Genetics United States | 1 | 1 |
|
Natera, Inc. United States | 265 | 274 |
|
Natera, Inc. United States | 265 | 274 |
|
Natera, Inc. United States | 265 | 274 |
|
Rhizomelic chondrodysplasia punctata: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 4 | 4 |
|
Chondrodysplasia Punctata NGS Panel Fulgent Genetics United States | 12 | 7 |
|
Beacon Expanded Female Carrier Screening Plus Panel Fulgent Genetics United States | 716 | 335 |
|
Beacon Expanded Male Carrier Screening Panel Fulgent Genetics United States | 636 | 298 |
|
Beacon Expanded Male Carrier Screening Plus Panel Fulgent Genetics United States | 661 | 306 |
|
Beacon Expanded Female Carrier Screening Panel Fulgent Genetics United States | 690 | 326 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.